EP 4294423 A1 20231227 - GIP/GLP1 DUAL AGONIST THERAPEUTIC METHODS
Title (en)
GIP/GLP1 DUAL AGONIST THERAPEUTIC METHODS
Title (de)
THERAPEUTISCHE VERFAHREN MIT DOPPELTEM GIP/GLP1-AGONISTEN
Title (fr)
PROCÉDÉS THÉRAPEUTIQUES AGONISTES DOUBLES GIP/GLP1
Publication
Application
Priority
- US 202163150408 P 20210217
- US 2022014971 W 20220202
Abstract (en)
[origin: WO2022177744A1] An embodiment of the invention relates to method for increasing HDL-C in a patient in need thereof. An embodiment of the invention relates to a method for decreasing high blood pressure. An embodiment relates to a treatment method for a patient with refractory type 2 diabetes to provide normal HbA1c glycemia.
IPC 8 full level
A61K 38/26 (2006.01); A61K 38/22 (2006.01); A61P 3/00 (2006.01); A61P 3/10 (2006.01); A61P 9/12 (2006.01)
CPC (source: EP)
A61K 38/22 (2013.01); A61K 38/26 (2013.01); A61P 3/00 (2017.12); A61P 3/10 (2017.12); A61P 9/12 (2017.12)
Citation (search report)
See references of WO 2022177744A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022177744 A1 20220825; CA 3208873 A1 20220825; CN 117320740 A 20231229; EP 4294423 A1 20231227; JP 2024508745 A 20240228
DOCDB simple family (application)
US 2022014971 W 20220202; CA 3208873 A 20220202; CN 202280015672 A 20220202; EP 22706153 A 20220202; JP 2023549546 A 20220202